Petra is an experienced healthcare leader with over 25 years of successful pharmaceutical commercialization track record. Petra joined Arvelle from Takeda Pharmaceuticals where she was SVP, Global Head of Rare Hematology Franchise, Global Product Strategy. Prior to that she held the position of SVP, Global Head of Internal Medicine Franchise, Global Strategic Marketing at Shire. While in these roles, Petra led the global launch of various brands, delivering strategic direction and guidance and preparing the organizations to launch products immediately once approved. Prior to her global strategic roles at Takeda and Shire, Petra held several Regional and General Manager leadership positions at Bayer. Petra started her career at Eli Lilly.